TrialPanorama/TrialPanorama-database huggingface dataset:
Study 19460773 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19460773 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 17515447 — Surrogate Endpoint (SUR): Blood pressure
Study 15300574 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9791046 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 2729751 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 30486858 — Surrogate Endpoint (SUR): Blood pressure
Study 28426123 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 28426123 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 28426123 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 28426123 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 14691688 — Surrogate Endpoint (SUR): Bone mineral density
Study 3729461 — Predictive Biomarker (PRD): AFM mRNA
Genes: AFM; ALB2; ALBA
Study 3729461 — Surrogate Endpoint (SUR): Blood pressure
Study 25028994 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25028994 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25028994 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7797925 — Safety Biomarker (SAF): Preexisting antibody
Study 23617551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16398842 — Surrogate Endpoint (SUR): Bone mineral density
Study 31511398 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 28115488 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 24829493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24829493 — Surrogate Endpoint (SUR): Blood pressure
Study 23033885 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 17123710 — Predictive Biomarker (PRD): RHOJ mRNA
Genes: RHOJ; ARHJ; RASL7B; RHOI; TCL
Study 9795455 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9795455 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 23972025 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 23972025 — Predictive Biomarker (PRD): Hormone receptor
Study 21164503 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 21164503 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29370352 — Predictive Biomarker (PRD): TLL1 mRNA
Genes: TLL1; TLL
Study 24021497 — Surrogate Endpoint (SUR): Blood pressure
Study 21917907 — Safety Biomarker (SAF): Cytochrome c
Study 17557312 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 12781882 — Surrogate Endpoint (SUR): Pathological complete response
Study 31831363 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 31831363 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 31593702 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 31593702 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 28165552 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28165552 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 28165552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26030518 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 26030518 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study 26030518 — Predictive Biomarker (PRD): Hormone receptor
Study 17303791 — Surrogate Endpoint (SUR): Blood pressure
Study 15519185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15519185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23922746 — Surrogate Endpoint (SUR): Blood pressure
Study 28409397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28409397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23294179 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 11451623 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8052956 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8052956 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8052956 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 20190833 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 6223289 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26787637 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26787637 — Surrogate Endpoint (SUR): Blood pressure
Study 17616777 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 17616777 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study 12471297 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12471297 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12471297 — Surrogate Endpoint (SUR): Blood pressure
Study 31999300 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 17157112 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 29897564 — Surrogate Endpoint (SUR): Bone mineral density
Study 29897564 — Surrogate Endpoint (SUR): Serum calcium
Study 26890560 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 24071376 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 30589994 — Predictive Biomarker (PRD): PTGDR2 mRNA
Genes: PTGDR2; CRTH2; DL1R; GPR44
Study 26794930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19074154 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 17487260 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28030526 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 25431482 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 17889121 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 11122017 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study 27203434 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 24225307 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 22728576 — Safety Biomarker (SAF): Hyaluronic acid
Study 10235547 — Surrogate Endpoint (SUR): Blood pressure
Study 8907805 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8907805 — Surrogate Endpoint (SUR): Blood pressure
Study 26422722 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 12190996 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 9807740 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 6753860 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 30411751 — Surrogate Endpoint (SUR): Blood pressure
Study 15234399 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11383794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22811030 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 11349696 — Surrogate Endpoint (SUR): Blood pressure
Study 7869731 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7869731 — Surrogate Endpoint (SUR): Blood pressure
Study 28093194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28093194 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 21126595 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19692265 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 19692265 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 19692265 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 15479494 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9825177 — Surrogate Endpoint (SUR): Blood pressure
Study 15228966 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 20110013 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 17203281 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8059818 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8059818 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8059818 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 8059818 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 2741619 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 9184261 — Surrogate Endpoint (SUR): Serum calcium
Study 27938540 — Predictive Biomarker (PRD): SOD3 mRNA
Genes: SOD3
Study 27938540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27938540 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 18436114 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18436114 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18436114 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9013088 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1524955 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29227294 — Surrogate Endpoint (SUR): Blood pressure
Study 18201563 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18201563 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 18201563 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24786228 — Surrogate Endpoint (SUR): Blood pressure
Study 18804988 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 29361312 — Surrogate Endpoint (SUR): Blood pressure
Study 20819564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10474783 — Surrogate Endpoint (SUR): Blood pressure
Study 10474783 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10474783 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1985608 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1985608 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21107305 — Surrogate Endpoint (SUR): Serum creatinine
Study 19008470 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 19008470 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 31932699 — Surrogate Endpoint (SUR): Blood pressure
Study 12067328 — Safety Biomarker (SAF): Interleukin 12
Study 12067328 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 9498655 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21704240 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 12177026 — Surrogate Endpoint (SUR): Blood pressure
Study 10459684 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 7608255 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 16007412 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 16007412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9802369 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 28657701 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 28657701 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 17918451 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 17918451 — Safety Biomarker (SAF): Hyaluronic acid
Study 15121738 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 11590989 — Surrogate Endpoint (SUR): Serum triglycerides
Study 29937267 — Surrogate Endpoint (SUR): Serum creatinine
Study 22543913 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 18415808 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 18415808 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 28548228 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 26217089 — Monitoring Biomarker (MOI): HBV DNA
Study 19747585 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 8431045 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26856250 — Predictive Biomarker (PRD): GRM7 mRNA
Genes: GRM7; GPRC1G; MGLUR7
Study 23324995 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19828907 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 8085692 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31955921 — Surrogate Endpoint (SUR): Blood pressure
Study 14709942 — Predictive Biomarker (PRD): TRIM32 mRNA
Genes: TRIM32; HT2A
Study 7875957 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 2839020 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26268494 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 12610738 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 30680400 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26626861 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23121378 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23121378 — Surrogate Endpoint (SUR): Serum creatinine
Study 23121378 — Surrogate Endpoint (SUR): Serum potassium
Study 10973534 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 27246726 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 27246726 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 27246726 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27246726 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 16225492 — Safety Biomarker (SAF): Reactive oxygen species
Study 21059743 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21059743 — Surrogate Endpoint (SUR): Blood pressure
Study 21059743 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 1820294 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1820294 — Surrogate Endpoint (SUR): Serum sodium
Study 22315052 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 15965572 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9663818 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 7512292 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 29045554 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 29045554 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study 17504795 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 28490871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 19126940 — Surrogate Endpoint (SUR): Blood pressure
Study 19126940 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 15455468 — Predictive Biomarker (PRD): ACSM3 mRNA
Genes: ACSM3; SAH
Study 31677820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31677820 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22053981 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17312651 — Surrogate Endpoint (SUR): Blood pressure
Study 15817423 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26033830 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26033830 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 17276051 — Surrogate Endpoint (SUR): Forced vital capacity
Study 9272426 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7519112 — Surrogate Endpoint (SUR): Blood pressure
Study 2900084 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16172147 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 14669843 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 30987963 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 30561402 — Surrogate Endpoint (SUR): Pathological complete response
Study 25209313 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 21205325 — Surrogate Endpoint (SUR): Blood pressure
Study 3763655 — Surrogate Endpoint (SUR): Blood pressure
Study 10523330 — Surrogate Endpoint (SUR): Blood pressure
Study 7047341 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 31319053 — Surrogate Endpoint (SUR): Blood pressure
Study 25970543 — Predictive Biomarker (PRD): CD247 mRNA
Genes: CD247; CD3Z; T3Z; TCRZ
Study 25970543 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25970543 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 25970543 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 25970543 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 25970543 — Predictive Biomarker (PRD): SNAI2 mRNA
Genes: SNAI2; SLUG; SLUGH
Study 25970543 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 25970543 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 23361158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23361158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23361158 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 23361158 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 19390704 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 19390704 — Surrogate Endpoint (SUR): Blood pressure
Study 17047649 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 17047649 — Surrogate Endpoint (SUR): Pathological complete response
Study 18990047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 18990047 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 16000961 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 16000961 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12387527 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8137624 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 8137624 — Surrogate Endpoint (SUR): Blood pressure
Study 21774987 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 1130305 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 26014293 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 19479252 — Surrogate Endpoint (SUR): Serum testosterone
Study 17286537 — Predictive Biomarker (PRD): GGH mRNA
Genes: GGH
Study 11100985 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 30777311 — Surrogate Endpoint (SUR): Bone mineral density
Study 27356240 — Surrogate Endpoint (SUR): Blood pressure
Study 27356240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25194850 — Surrogate Endpoint (SUR): Blood pressure
Study 19959493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19959493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19959493 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 20727 — Surrogate Endpoint (SUR): Blood pressure
Study 17682320 — Surrogate Endpoint (SUR): Blood pressure
Study 30802723 — Surrogate Endpoint (SUR): Serum potassium
Study 30802723 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18982377 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 23322524 — Predictive Biomarker (PRD): Hormone receptor
Study 17302696 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11691524 — Surrogate Endpoint (SUR): Blood pressure
Study 31246894 — Surrogate Endpoint (SUR): Blood pressure
Study 25043067 — Predictive Biomarker (PRD): IKZF2 mRNA
Genes: IKZF2; HELIOS; ZNFN1A2
Study 20353434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study 18203072 — Surrogate Endpoint (SUR): Blood pressure
Study 16409523 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 10879416 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10879416 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6472116 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30277539 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 18375253 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30475165 — Surrogate Endpoint (SUR): Blood pressure
Study 30481229 — Surrogate Endpoint (SUR): Blood pressure
Study 20498136 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 12699797 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 26619359 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26619359 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 23772084 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11049977 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34